Immune aging biomarkers for clinical trials

The authors present a framework for the selection of immune aging biomarkers suitable for clinical trials in geroscience, alongside a translational roadmap for biomarker development to support the next generation of clinical studies on immune aging.

This story was reported by Nature.com. EUROPES curates Europe's most relevant coverage — read the full report at the original source.